Stock Research for CELG

CELG

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

CELG Stock Chart & Research Data

The CELG chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CELG chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


CELG Due diligence Resources & Stock Charts

The CELG stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CELG Detailed Price Forecast - CNN Money CNN View CELG Detailed Summary - Google Finance
Yahoo View CELG Detailed Summary - Yahoo! Finance Zacks View CELG Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View CELG Trends & Analysis - Trade-Ideas Barrons View CELG Major Holders - Barrons
NASDAQ View CELG Call Transcripts - NASDAQ Seeking View CELG Breaking News & Analysis - Seeking Alpha
Spotlight View CELG Annual Report - CompanySpotlight.com OTC Report View CELG OTC Short Report - OTCShortReport.com
TradeKing View CELG Fundamentals - TradeKing Charts View CELG SEC Filings - Bar Chart
WSJ View Historical Prices for CELG - The WSJ Morningstar View Performance/Total Return for CELG - Morningstar
MarketWatch View the Analyst Estimates for CELG - MarketWatch CNBC View the Earnings History for CELG - CNBC
StockMarketWatch View the CELG Earnings - StockMarketWatch MacroAxis View CELG Buy or Sell Recommendations - MacroAxis
Bullish View the CELG Bullish Patterns - American Bulls Short Pains View CELG Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View CELG Stock Mentions - StockTwits PennyStocks View CELG Stock Mentions - PennyStockTweets
Twitter View CELG Stock Mentions - Twitter Invest Hub View CELG Investment Forum News - Investor Hub
Yahoo View CELG Stock Mentions - Yahoo! Message Board Seeking Alpha View CELG Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for CELG - SECform4.com Insider Cow View Insider Transactions for CELG - Insider Cow
CNBC View CELG Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CELG - OTC Markets
Yahoo View Insider Transactions for CELG - Yahoo! Finance NASDAQ View Institutional Holdings for CELG - NASDAQ


Stock Charts

FinViz View CELG Stock Insight & Charts - FinViz.com StockCharts View CELG Investment Charts - StockCharts.com
BarChart View CELG Stock Overview & Charts - BarChart Trading View View CELG User Generated Charts - Trading View


Latest Financial News for CELG

CELG SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Celgene Corporation and a Lead Plaintiff Deadline of May 29, 2018
Posted on Monday April 23, 2018

NEW YORK, April 23, 2018-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors ...


After headline drug flops in trials, Peninsula biotech sheds 70% of its value
Posted on Monday April 23, 2018

The South San Francisco company halted development of a drug for a rare protein-misfolding condition that causes heart problems, resulting in a $534 million drop in market value.


Biotech Stocks Face a Steep Drop
Posted on Monday April 23, 2018

An analysis of Biotech ETF XBI's chart suggests the sector could be set for a decline of over 8%.


2 Beta Thalassemia Drugs Are Fast Approaching the Finish Line
Posted on Sunday April 22, 2018

New treatments could be coming from Celgene and bluebird bio that reshape how we treat this life-threatening gene disorder.


Enter a stock symbol to view the stock details.